These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Identification of a novel de novo mutation of SETBP1 and new findings of SETBP1 in tumorgenesis. Wang H; Gao Y; Qin L; Zhang M; Shi W; Feng Z; Guo L; Zhu B; Liao S Orphanet J Rare Dis; 2023 May; 18(1):107. PubMed ID: 37150818 [TBL] [Abstract][Full Text] [Related]
29. Novel SETBP1 mutation in a chinese family with intellectual disability. Wang L; Wang XD; Yang B; Wang XM; Peng YQ; Tan HJ; Xiao HM BMC Med Genomics; 2023 Oct; 16(1):233. PubMed ID: 37798664 [TBL] [Abstract][Full Text] [Related]
30. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Piazza R; Valletta S; Winkelmann N; Redaelli S; Spinelli R; Pirola A; Antolini L; Mologni L; Donadoni C; Papaemmanuil E; Schnittger S; Kim DW; Boultwood J; Rossi F; Gaipa G; De Martini GP; di Celle PF; Jang HG; Fantin V; Bignell GR; Magistroni V; Haferlach T; Pogliani EM; Campbell PJ; Chase AJ; Tapper WJ; Cross NC; Gambacorti-Passerini C Nat Genet; 2013 Jan; 45(1):18-24. PubMed ID: 23222956 [TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis. Shou LH; Cao D; Dong XH; Fang Q; Wu Y; Zhang Y; Fei JP; Xu BL PLoS One; 2017; 12(2):e0171608. PubMed ID: 28158286 [TBL] [Abstract][Full Text] [Related]
35. Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS. Kanagal-Shamanna R; Luthra R; Yin CC; Patel KP; Takahashi K; Lu X; Lee J; Zhao C; Stingo F; Zuo Z; Routbort MJ; Singh RR; Fox P; Ravandi F; Garcia-Manero G; Medeiros LJ; Bueso-Ramos CE Oncotarget; 2016 Mar; 7(12):14251-8. PubMed ID: 26883102 [TBL] [Abstract][Full Text] [Related]
36. SETBP1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. Yao XY; Zhou JD; Yang J; Zhang W; Ma JC; Wen XM; Yao DM; Xu ZJ; Wu DH; He PF; Qian J; Lin J Pathol Res Pract; 2018 May; 214(5):706-712. PubMed ID: 29549983 [TBL] [Abstract][Full Text] [Related]
37. SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia. Cristóbal I; Blanco FJ; Garcia-Orti L; Marcotegui N; Vicente C; Rifon J; Novo FJ; Bandres E; Calasanz MJ; Bernabeu C; Odero MD Blood; 2010 Jan; 115(3):615-25. PubMed ID: 19965692 [TBL] [Abstract][Full Text] [Related]
38. [Unusual facies with delayed development and multiple malformations in a 14-month-old boy]. Lu T; Wang Y Zhongguo Dang Dai Er Ke Za Zhi; 2017 Aug; 19(8):921-925. PubMed ID: 28774369 [TBL] [Abstract][Full Text] [Related]
39. Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies. Winkelmann N; Schäfer V; Rinke J; Kaiser A; Ernst P; Scholl S; Hochhaus A; Ernst T J Cancer Res Clin Oncol; 2017 Dec; 143(12):2511-2519. PubMed ID: 28913558 [TBL] [Abstract][Full Text] [Related]
40. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Meggendorfer M; Bacher U; Alpermann T; Haferlach C; Kern W; Gambacorti-Passerini C; Haferlach T; Schnittger S Leukemia; 2013 Sep; 27(9):1852-60. PubMed ID: 23628959 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]